# ALOX12

## Overview
ALOX12 is a gene that encodes the enzyme arachidonate 12-lipoxygenase, 12S type, which is a member of the lipoxygenase family of enzymes. This enzyme is primarily involved in the metabolism of arachidonic acid, leading to the production of bioactive lipid mediators such as 12-hydroxyeicosatetraenoic acid (12-HETE). Arachidonate 12-lipoxygenase plays a crucial role in various physiological processes, including the regulation of oxidative stress, inflammation, and vascular function. It is predominantly expressed in platelets, megakaryocytes, and the epidermis, where it influences platelet aggregation and vascular homeostasis. The enzyme's activity is modulated by several factors, including interactions with other proteins and external stimuli, which can impact its role in cellular signaling pathways. ALOX12 has been implicated in several clinical conditions, including cancer and bone disorders, highlighting its significance in both health and disease (Zheng2020The; Harsløf2010Polymorphisms; Weng2022ALOX12:).

## Structure
The ALOX12 gene encodes the enzyme arachidonate 12-lipoxygenase, which is involved in the metabolism of arachidonic acid to produce 12-hydroxyeicosatetraenoic acid (12-HETE). The enzyme's structure includes a catalytic domain located in the C-terminal region, which is crucial for its enzymatic activity (Mashima2015The). The N-terminal domain, although not directly affecting substrate specificity, plays a role in regulating enzymatic activity, as its truncation reduces the enzyme's activity (Mashima2015The).

ALOX12 is characterized by a primary structure rich in iron-binding sites, which are essential for its catalytic function. The secondary structure predominantly consists of alpha-helices, contributing to the formation of the catalytic domain. The enzyme may also exhibit a quaternary structure through dimerization, which can influence its functional properties (Kuhn2015Mammalian).

Common post-translational modifications of ALOX12 include phosphorylation, which can affect its activity and localization. The gene may also have splice variant isoforms, potentially altering its function and interaction with other cellular components (Witola2014ALOX12). These structural features are critical for the enzyme's role in various physiological and pathological processes.

## Function
The ALOX12 gene encodes the enzyme arachidonate 12-lipoxygenase, which plays a significant role in the metabolism of arachidonic acid to produce 12-hydroxyeicosatetraenoic acid (12-HETE). This enzyme is primarily expressed in platelets, megakaryocytes, and the epidermis, where it influences various biological processes (Zheng2020The). In healthy human cells, ALOX12 is involved in the regulation of oxidative stress and inflammation by modulating the production of reactive oxygen species (ROS) and influencing the activity of NADPH oxidase (Zheng2020The). It also plays a role in vascular function by affecting the contraction and relaxation of blood vessels and regulating platelet aggregation through the production of 12-HETrE, which increases cAMP levels in platelets (Zheng2020The).

ALOX12 contributes to cellular homeostasis by balancing oxidative stress and inflammation, which is crucial for maintaining normal physiological functions. It is involved in the biosynthesis of lipoxins, anti-inflammatory mediators that enhance the host's defense against bacterial infections (Zheng2020The). The enzyme's activity is modulated by various factors, including estrogen and nitric oxide, and its expression can be influenced by external stimuli such as pro-inflammatory cytokines (Zheng2020The).

## Clinical Significance
The ALOX12 gene has significant clinical implications in various diseases due to its altered expression and mutations. In colorectal cancer (CRC), high ALOX12 expression is associated with worse overall survival, recurrence-free survival, and progression-free survival. It is linked to tumor development, progression, metastasis, and immune-related pathways. Knockdown of ALOX12 in CRC cell lines reduces proliferation, invasion, and metastasis, highlighting its role in promoting these processes. High ALOX12 expression correlates with increased immune cell infiltration and upregulation of immune checkpoints, suggesting potential benefits from immune checkpoint blockade therapies (Weng2022ALOX12:).

In myelodysplastic syndromes (MDS), ALOX12 expression is highly susceptible to 5-azacytidine (AZA) treatment. The gene's expression levels are closely correlated with disease progression, and higher methylation levels of ALOX12 are observed in MDS compared to healthy controls. Lower ALOX12 expression is associated with higher bone marrow blasts, indicating a potential role in suppressing bone marrow blastogenesis and tumor progression. A Kaplan-Meier analysis showed better prognosis for MDS patients with high ALOX12 expression, suggesting its potential as a tumor suppressor (Matsumoto2024Enhanced).

Polymorphisms in the ALOX12 gene have been linked to bone mineral density (BMD) and fracture risk, particularly in osteoporosis. Certain polymorphisms are associated with decreased lumbar spine BMD and increased vertebral fracture risk, suggesting that genetic variants in ALOX12 may influence osteoporosis pathogenesis (Harsløf2010Polymorphisms).

## Interactions
ALOX12, or arachidonate 12-lipoxygenase, 12S type, is known to interact with several proteins, influencing various cellular processes. ALOX12 specifically binds with SLC7A11, a protein that suppresses its lipoxygenase activity in a dosage-dependent manner. This interaction is crucial for the regulation of ALOX12's enzymatic activity and is significant in the context of p53-mediated ferroptosis, where p53 can promote ALOX12 function by downregulating SLC7A11 (Chu2019ALOX12). 

ALOX12 also interacts with the RUNX1 transcription factor, which can bind to its promoter region, affecting its transcription and suggesting a regulatory interaction at the DNA level (Zheng2020The). Additionally, ALOX12 is involved in the ALOX12/TRPV1/PKC signaling pathway, where it influences the activity of TRPV1, a non-selective cation channel protein, through the production of 12-HETE (Zheng2020The). 

While ALOX12's interactions with other proteins and nucleic acids are not extensively detailed, its role in forming dimers in aqueous solutions suggests potential protein-protein interactions (Kuhn2015Mammalian). These interactions highlight ALOX12's involvement in complex cellular signaling pathways and its regulatory functions in various biological processes.


## References


[1. (Kuhn2015Mammalian) Hartmut Kuhn, Swathi Banthiya, and Klaus van Leyen. Mammalian lipoxygenases and their biological relevance. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 1851(4):308–330, April 2015. URL: http://dx.doi.org/10.1016/j.bbalip.2014.10.002, doi:10.1016/j.bbalip.2014.10.002. This article has 432 citations.](https://doi.org/10.1016/j.bbalip.2014.10.002)

[2. (Chu2019ALOX12) Bo Chu, Ning Kon, Delin Chen, Tongyuan Li, Tong Liu, Le Jiang, Shujuan Song, Omid Tavana, and Wei Gu. Alox12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway. Nature Cell Biology, 21(5):579–591, April 2019. URL: http://dx.doi.org/10.1038/s41556-019-0305-6, doi:10.1038/s41556-019-0305-6. This article has 517 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41556-019-0305-6)

[3. (Zheng2020The) Zhonghua Zheng, Yin Li, Gehui Jin, Tianyi Huang, Mengsha Zou, and Shiwei Duan. The biological role of arachidonic acid 12-lipoxygenase (alox12) in various human diseases. Biomedicine &amp; Pharmacotherapy, 129:110354, September 2020. URL: http://dx.doi.org/10.1016/j.biopha.2020.110354, doi:10.1016/j.biopha.2020.110354. This article has 67 citations.](https://doi.org/10.1016/j.biopha.2020.110354)

[4. (Harsløf2010Polymorphisms) T. Harsløf, L. B. Husted, M. Nyegaard, M. Carstens, L. Stenkjær, K. Brixen, P. Eiken, J-E. B. Jensen, A. D. Børglum, L. Mosekilde, L. Rejnmark, and B. L. Langdahl. Polymorphisms in the alox12 gene and osteoporosis. Osteoporosis International, 22(8):2249–2259, November 2010. URL: http://dx.doi.org/10.1007/s00198-010-1472-2, doi:10.1007/s00198-010-1472-2. This article has 12 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00198-010-1472-2)

[5. (Weng2022ALOX12:) Siyuan Weng, Zaoqu Liu, Hui Xu, Xiaoyong Ge, Yuqing Ren, Qin Dang, Long Liu, Jian Zhang, Peng Luo, Jianzhuang Ren, and Xinwei Han. Alox12: a novel insight in bevacizumab response, immunotherapy effect, and prognosis of colorectal cancer. Frontiers in Immunology, June 2022. URL: http://dx.doi.org/10.3389/fimmu.2022.910582, doi:10.3389/fimmu.2022.910582. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fimmu.2022.910582)

[6. (Mashima2015The) Ryuichi Mashima and Torayuki Okuyama. The role of lipoxygenases in pathophysiology; new insights and future perspectives. Redox Biology, 6:297–310, December 2015. URL: http://dx.doi.org/10.1016/j.redox.2015.08.006, doi:10.1016/j.redox.2015.08.006. This article has 298 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.redox.2015.08.006)

[7. (Witola2014ALOX12) William H. Witola, Susan Ruosu Liu, Alexandre Montpetit, Ruth Welti, Magali Hypolite, Mary Roth, Ying Zhou, Ernest Mui, Marie-France Cesbron-Delauw, Gilbert J. Fournie, Pierre Cavailles, Cordelia Bisanz, Kenneth Boyer, Shawn Withers, A. Gwendolyn Noble, Charles N. Swisher, Peter T. Heydemann, Peter Rabiah, Stephen P. Muench, and Rima McLeod. Alox12 in human toxoplasmosis. Infection and Immunity, 82(7):2670–2679, July 2014. URL: http://dx.doi.org/10.1128/iai.01505-13, doi:10.1128/iai.01505-13. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1128/iai.01505-13)

[8. (Matsumoto2024Enhanced) Taichi Matsumoto, Yuichi Murakami, Nao Yoshida-Sakai, Daisuke Katsuchi, Kuon Kanazawa, Takashi Okamura, Yutaka Imamura, Mayumi Ono, and Michihiko Kuwano. Enhanced alox12 gene expression predicts therapeutic susceptibility to 5-azacytidine in patients with myelodysplastic syndromes. International Journal of Molecular Sciences, 25(9):4583, April 2024. URL: http://dx.doi.org/10.3390/ijms25094583, doi:10.3390/ijms25094583. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms25094583)